NASDAQ:VRCA
Verrica Pharmaceuticals Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.verrica.comipo date
Jun 15, 2018
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical tria...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus